Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP846857.RAf5Lbq3F9tu_PsiKLG_3FDSny7v8_h4Y6hEURV2GVDdA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP846857.RAf5Lbq3F9tu_PsiKLG_3FDSny7v8_h4Y6hEURV2GVDdA130_assertion type Assertion NP846857.RAf5Lbq3F9tu_PsiKLG_3FDSny7v8_h4Y6hEURV2GVDdA130_head.
- NP846857.RAf5Lbq3F9tu_PsiKLG_3FDSny7v8_h4Y6hEURV2GVDdA130_assertion description "[We have shown for the first time that despite an increase in AGR2 expression in prostate cancer compared to non-malignant cells, relatively lower levels of AGR2 are highly predictive of disease recurrence following radical prostatectomy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP846857.RAf5Lbq3F9tu_PsiKLG_3FDSny7v8_h4Y6hEURV2GVDdA130_provenance.
- NP846857.RAf5Lbq3F9tu_PsiKLG_3FDSny7v8_h4Y6hEURV2GVDdA130_assertion evidence source_evidence_literature NP846857.RAf5Lbq3F9tu_PsiKLG_3FDSny7v8_h4Y6hEURV2GVDdA130_provenance.
- NP846857.RAf5Lbq3F9tu_PsiKLG_3FDSny7v8_h4Y6hEURV2GVDdA130_assertion SIO_000772 21144054 NP846857.RAf5Lbq3F9tu_PsiKLG_3FDSny7v8_h4Y6hEURV2GVDdA130_provenance.
- NP846857.RAf5Lbq3F9tu_PsiKLG_3FDSny7v8_h4Y6hEURV2GVDdA130_assertion wasDerivedFrom befree-20150227 NP846857.RAf5Lbq3F9tu_PsiKLG_3FDSny7v8_h4Y6hEURV2GVDdA130_provenance.
- NP846857.RAf5Lbq3F9tu_PsiKLG_3FDSny7v8_h4Y6hEURV2GVDdA130_assertion wasGeneratedBy ECO_0000203 NP846857.RAf5Lbq3F9tu_PsiKLG_3FDSny7v8_h4Y6hEURV2GVDdA130_provenance.